Purchase Order 75N93024P00868

Award Date 7/17/24
Potential Completion Date 9/19/24
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Yaphank, NY 11967, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
CD Biosciences Inc., doing business as Creative Biomart, was awarded a $58,206 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide genotyping and sequencing services for microbiome analysis in human papillomavirus-related diseases. The contract calls for Creative Biomart to deliver the requested products and services in support of NIAID's research into the role of the microbiome in HPV-associated conditions...
This federal contract award, valued at $99,300.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for HPV/HIV study and analysis services, including sequencing and library preparation, to support research on the immunological and biological correlates of HPV infection clearance versus persistence, as well as the evaluation of the vaginal...
This federal contract award for $22,360.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for gynotyping and sequencing services, with a completion date of September 17, 2024. CD Biosciences Inc., doing business as Creative Biomart, specializes in genomic sequencing, bioinformatics analysis, and other laboratory services to support research...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to CD Biosciences Inc., doing business as Creative Biomart, for COVID-19 next-generation sequencing services. The $24,450.00 contract has a period of performance through September 20, 2022. CD Biosciences Inc. is a research product supplier and contract research organization that provides a wide range of specialized molecular biology services to federal agencies,...
This is a $13,380 firm fixed-price purchase order awarded to CD Biosciences Inc., a small business research product supplier and contract research organization, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for TCR sequencing services, with a period of performance through August 4, 2025. CD Biosciences provides specialized scientific services, including genomic sequencing, bioinformatics analysis, and molecular biology, to support research across various...
This federal contract award, with an ID of 75N91021P00756, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $95,995 firm-fixed-price purchase order was awarded to Atila Biosystems Incorporated, a small business, to provide HPV genotyping assays and testing supplies to support the NCI's Division of Cancer Epidemiology and Genetics (DCEG) research efforts. The contract was...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
This federal contract award, valued at $15,575.00, was issued by the National Heart Lung and Blood Institute (NHLBI) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for the provision of RNA sequencing services for 115 samples, with a completion date of May 22, 2020. The contract is a firm fixed-price purchase order, and is designated as a total small business set-aside. CD Biosciences Inc. operates under multiple divisions,...
The U.S. government has awarded a $22,890.00 Firm Fixed Price purchase order contract to CD Biosciences Inc., doing business as Creative Biomart, a small business provider of biotechnology services. The contract, which is a set-aside for small businesses, is for the "SEQUENCING CMBS INSECT PROGRAM" and has an ultimate completion date of July 30, 2024. CD Biosciences Inc. is a small business that specializes in genomic sequencing, bioinformatics analysis, and other molecular biology...
This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...

This firm-fixed-price purchase order, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., doing business as Creative Biomart, provides $55,100.00 for HPV genotyping and 16S rRNA sequencing services. The contract supports research on the progression of HPV-related diseases and dysplasia in individuals with primary and acquired immunodeficiencies. CD Biosciences, an incumbent supplier, will conduct HPV genotyping for 210 types and 16S rRNA sequencing for 106 samples to help identify HPV variants, their persistence, and changes in the bacterial microbiome. The award is not set aside for any specific business category. This contract leverages CD Biosciences' expertise in genomic analysis services to support NIAID's research on the clinical severity of HPV-related manifestations and their correlation with HPV variants and the microbiome.

Generated 7/17/24, 9:47 AM